FAST BioMedical Inc. is an early-stage emerging technology company providing diagnostic tests involving physiological parameters that have previously been difficult or impossible to measure, including plasma volume and glomerular filtration rate (GFR), which measures the degree of kidney filtration -- potentially having profound impact on care of congestive heart failure, major surgery, sepsis, critical care, and kidney disease patients. With the exclusive license for a proprietary technology developed by the Indiana Center for Biological Microscopy, FAST's premier product is a device utilizing proprietary technology that offers rapid detection of acute kidney injury and chronic kidney-related diseases using a sensitive measurement of true kidney function and plasma volume.
